# Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series

**Authors:** Regina Berkovich, Jonathan Calkwood, Heidi Crayton, April Erwin, Simon Faissner, Ralf Gold, Joshua Katz, Mark Leekoff

PMC · DOI: 10.3389/fimmu.2025.1609054 · Frontiers in Immunology · 2025-06-13

## Full-text entities

- **Chemicals:** anti- (-), ublituximab (MESH:C000619007)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12203560/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12203560/full.md

---
Source: https://tomesphere.com/paper/PMC12203560